Palisaded neutrophilic and granulomatous dermatitis in a rheumatoid arthritis patient after treatment with adalimumab

被引:5
作者
Umezawa, Yoshinori [1 ]
Ito, Keigo [1 ]
Nakagawa, Hidemi [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan
关键词
THERAPY;
D O I
10.1684/ejd.2013.2197
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:910 / 911
页数:3
相关论文
共 50 条
  • [21] A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis
    Fleischmann, Roy M.
    Alten, Rieke
    Pileckyte, Margarita
    Lobello, Kasia
    Hua, Steven Y.
    Cronenberger, Carol
    Alvarez, Daniel
    Bock, Amy E.
    Sewell, K. Lea
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [22] Lupus Cardiomyopathy and Nephritis Associated With Adalimumab and Cytomegalovirus Infection in a Patient With Seronegative Rheumatoid Arthritis: A Case of Rhupus Syndrome
    Waitayangkoon, Palapun
    Chen, Lucas
    Liu, Jessica B.
    Weins, Astrid
    Barbosa, Felipe
    Treadwell, Thomas
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [23] Therapeutic Options After Treatment Failure in Rheumatoid Arthritis or Spondyloarthritides
    Govoni, Marcello
    Bortoluzzi, Alessandra
    Lo Monaco, Andrea
    Adami, Silvano
    Addimanda, Olga
    Caimmi, Cristian
    De Vita, Salvatore
    Ferri, Clodoveo
    Manfredi, Andreina
    Orsolini, Giovanni
    Possemato, Niccolo
    Quartuccio, Luca
    Salvarani, Carlo
    Zabotti, Alen
    Rossini, Maurizio
    ADVANCES IN THERAPY, 2014, 31 (08) : 780 - 802
  • [24] Therapeutic Options After Treatment Failure in Rheumatoid Arthritis or Spondyloarthritides
    Marcello Govoni
    Alessandra Bortoluzzi
    Andrea Lo Monaco
    Silvano Adami
    Olga Addimanda
    Cristian Caimmi
    Salvatore De Vita
    Clodoveo Ferri
    Andreina Manfredi
    Giovanni Orsolini
    Niccolò Possemato
    Luca Quartuccio
    Carlo Salvarani
    Alen Zabotti
    Maurizio Rossini
    Advances in Therapy, 2014, 31 : 780 - 802
  • [25] Myocardial Infarction after Rituximab Treatment for Rheumatoid Arthritis: Is there a Link?
    van Sijl, Alper M.
    van der Weele, Wilfred
    Nurmohamed, Michael T.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (04) : 496 - 499
  • [26] Decrease of CD68 and MMP-3 expression in synovium by treatment of adalimumab for rheumatoid arthritis
    Kanbe, Katsuaki
    Chiba, Junji
    Nakamura, Atsushi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2011, 14 (03) : 261 - 266
  • [27] Patient's experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
    Curtis, J. R.
    Xie, F.
    Mackey, D.
    Gerber, N.
    Bharat, A.
    Beukelman, T.
    Saag, K. G.
    Chen, L.
    Nowell, B.
    Ginsberg, S.
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17
  • [28] Efficacy of adalimumab combined with Tripterygium wilfordii Hook F in the treatment of patient with rheumatoid arthritis: A multicenter, open-label, randomized-controlled trial
    Luo, Feng
    Gau, Shuo-Yan
    Wu, Yu-xia
    Liao, Hou-li
    Tang, Fang
    Zhong, Qin
    Huang, Ying
    Hou, Lei
    Liu, Zheng-qi
    Cai, Jin-long
    Cao, Yue-peng
    Lu, Dao-min
    An, Yang
    Lan, Wei-ya
    Liu, Can
    Chen, Chang-ming
    Jia, Er-tao
    Yao, Xue-ming
    Wei, James Cheng-Chung
    Ma, Wu-kai
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)
  • [29] Progressive Multifocal Leukoencephalopathy Following Rituximab Treatment in a Patient With Rheumatoid Arthritis
    Fleischmann, R. M.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (11): : 3225 - 3228
  • [30] CHARACTERISTICS OF PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WHO HAVE A DELAYED RESPONSE TO TREATMENT WITH METHOTREXATE IN MONOTHERAPY OR IN COMBINATION WITH ADALIMUMAB
    Smolen, J.
    Bu, X.
    Wang, X.
    Suboticki, J.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 605 - 605